Lung Cancer Patients Should Be Screened For MET Oncogene Amplification, Research Suggests

"Our study suggests that patients with a MET oncogene amplification will not respond to immunotherapy alone and will require treatment with a combination of a MET inhibitor together with immunotherapy,"

Cancer Research: What’s Exciting The Experts?

Medical News Today spoke with a group of scientists and clinicians who specialize in the field.

Cancer Research UK Partners With Aleta Biotherapeutics On Blood Cancer Therapy

“There is an urgent need to develop new therapies that can help people with B-cell cancers, such as lymphoma and leukaemia, whose cancer has progressed after treatment with CD19 CAR-T cell therapy,”

Takeda Reports Promising Results For Lung Cancer Treatment

Mobocertinib is the first small-molecule TKI specifically designed to selectively target EGFR Exon20 insertions in patients with mNSCLC and demonstrated clinical proof-of-concept in these patients.

Moffitt Cancer Center Awarded $10.2 Million Grant For Lung Cancer Research

Lung cancer is the leading cause of cancer deaths across the globe with 1.8 million deaths in 2020, according to the World Health Organization.